頁籤選單縮合
題名 | The Clinical Significance of Serum Ferritin Levels in Hepatic Disorders=血中鐵蛋白變化在肝臟異常病人之臨床意義 |
---|---|
作者 | 廖炎智; 黃文盛; 唐鴻舜; 陳維廉; 吳興鏞; Liao, Yan-chih; Huang, Wen-sheng; Tang, Hung-shang; Chen, Wei-lian; Wu, Sing-yung; Florsheim,Warner H.; |
期刊 | 核子醫學雜誌 |
出版日期 | 19960400 |
卷期 | 9:2 1996.04[民85.04] |
頁次 | 頁49-52 |
分類號 | 415.53 |
語文 | eng |
關鍵詞 | 血中鐵蛋白變化; 肝臟異常病人; Acute hepatitis B; Chronic hepatitis B; Cirrhosis of liver; Hepatocellular carcinoma; |
英文摘要 | Background: Serum ferritin levels were studied to assess the clinical significance of variations in serum ferritin levels between different liver diseases. Methods: Subjects were divided into control in=45) and diseased (n=147) groups. The diseased group was further subdivided as acute hepatitis B in acute (AHA) and resolution (AHR) stages, chronic hepatitis B in inactive (CHI) and acute exacerbation ICHAE) stages, cirrhosis of the fiver (LC) and hepatocellular carcinoma (HCC). Serum ferritin was measured by radioimmunoassay. Results: The serum ferritin levels of the normal controls were 112 ± 6.9 mg/mL (mean ± SE). All 21 patients with AHA, 62.5% (10/16) of CHAE patients, 15% (3/20) of LC patients and 15% (3/21) of HCC patients had serum ferritin levels greater than 600 ng/mL. Except for those with CHI, there was significant difference in the changes of serum ferritin levels between control and diseased groups (p<0.01 & p < 0.005). Conclusion: A high proportion of patients with hepatic disorders have elevated serum ferritin during active or exacerbation periods. |
本系統之摘要資訊系依該期刊論文摘要之資訊為主。